Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

Corcept Therapeutics (NASDAQ:CORT) said on Thursday that the mid-stage study of its cortisol modulator, dazucorilant, in ...

The FDA has granted fast-track designation to an investigational antisense oligonucleotide that targets a specific driver of ...

Experts predict cases will rise by 2030, affecting hundreds of Michigan families battling the fatal condition.

Officials said Michigan is now the fifth state in the country to require healthcare professions to report cases of the ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

An impactful moment at Dodger Stadium, not just for Jason Ramirez and his family, but the thousands who watched as the former ...

Jacifusen was generally well tolerated and reversed disease progression in some people with ALS caused by mutations in the ...

The Everylife Foundation for Rare Diseases is offering a new scholarship for U.S. students from the ALS community facing ...

Brad G. Smith, an ALS patient, regains communication abilities with a Neuralink implant, illustrating the potential of brain-computer interfaces in aiding speech impairments.

As part of ALS Awareness Month, the Miami Marlins recognized Lou Gehrig’s legacy and the fight against ALS during a special ...

Families affected by ALS are biking 150 miles from Oxford, Maine to Boxford, Massachusetts to raise funds for research and ...